News Results
There are 79,467 News Results
Jul 31, 2018
SALT LAKE CITY, July 31, 2018 /PRNewswire-PRWeb/ -- Lone Peak Biologics is thrilled to announce the latest addition to its industry-leading line of human biologics products: AmnioShot(TM) . AmnioShot(TM) is...
Aug 1, 2018
NEW YORK, Aug. 1, 2018 /PRNewswire/ -- Baker's yeast survive and grow after a drastic reorganization, not of their genes, but of the chromosome superstructures that house, protect and control...
Aug 10, 2018
PORTLAND, Oregon, August 10, 2018 /PRNewswire/ -- According to a new report published by Allied Market Research, titled, Curcumin Market [ https://www.alliedmarketresearch.com/curcumin-market ] by Application: Global Opportunity Analysis and Industry...
Aug 28, 2018
SAN DIEGO, Aug. 28, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from two Phase 1 clinical studies evaluating an extended-release (XR) formulation of its investigative...
Sep 11, 2018
NORTH CHICAGO, Ill., Sept. 11, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has expanded the label for...
Sep 19, 2018
LOS ANGELES, Sept. 19, 2018 /PRNewswire/ -- Zynx Health (TM), a market leader in providing evidence- and experience-based clinical improvement solutions since 1996, today announced the launch of ZynxPeds, a...
Sep 25, 2018
DURHAM, N.C., Sept. 25, 2018 /PRNewswire/ -- The Respiratory Compromise Institute today announced the initiation of a clinical study aimed at better understanding the prevalence, risk factors and pathways for...
Oct 10, 2018
GAITHERSBURG, Md., Oct. 10, 2018 /PRNewswire/ -- MaxCyte, the global cell-based medicines and life sciences company, announced today that the first patient has been dosed in its Phase I dose-escalation...
Jun 4, 2017
NESS ZIONA, Israel, June 5, 2017 /PRNewswire/ -- Israeli biotechnology company Kadimastem (TASE: KDST) announces a yearly budget approved by the Innovation Authority in the total amount of NIS 12...
Jun 7, 2017
STANS, Switzerland and INDIANAPOLIS, June 8, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and KeyBioscience AG have agreed to a new collaboration focused on the development of Dual...